SCYX Q1 2020 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$12M

Net Income

-$7M

EPS (Diluted)

$-0.72

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$410,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$35M

Stockholders' Equity

$6M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$64,000	-100.0%
Gross Profit	$0	$64,000	-100.0%
Operating Income	-$12M	-$12M	-5.2%
Net Income	-$7M	-$23M	+69.4%